How large is the stratagraft market, and what is its growth trajectory?
The stratagraft market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increasing burn injury rates, rising healthcare expenditures, growing awareness about advanced wound care, expanding clinical applications of bioengineered skin, regulatory approvals for skin substitutes, and demand for effective burn treatment solutions.
The stratagraft market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to the rising incidence of diabetes and obesity, a growing aging population, increasing industrial accidents, higher adoption of bioengineered solutions, supportive government policies, growing healthcare infrastructure in emerging markets, and escalating prevalence of chronic wounds. Major trends in the forecast period include gradual adoption of skin substitutes, focus on reducing donor site morbidity, increasing clinical trials for bioengineered products, advancements in skin substitute technology, and advancements in burn care protocols.
Get Your Free Sample of The Global StrataGraft Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20359&type=smp
What are the key forces behind the stratagraft market’s growth in recent years?
The rising incidence of chronic wounds and burn injuries is expected to propel the growth of the stratagraft market going forward. Chronic wounds and burn injuries refer to conditions where skin or underlying tissue is damaged, with chronic wounds characterized by prolonged healing times due to factors such as diabetes or poor circulation, and burn injuries caused by exposure to thermal, chemical, or electrical agents that often require advanced medical treatment for repair and recovery. The increase in chronic wounds and burn injuries is driven by the rising prevalence of diabetes, obesity, an aging population, industrial accidents, and poor access to preventive care in many regions. Stratagraft serves as an advanced treatment option addressing chronic wounds and burn injuries by offering a bioengineered alternative to traditional skin grafts, promoting effective wound healing while reducing the need for donor site procedures. For instance, in October 2023, according to the World Health Organization (WHO), a US-based public health agency, globally, about 180,000 deaths are caused by burns annually, with the majority occurring in low- and middle-income countries. In the United States, there were an estimated 410,000 burn injuries in 2023, with approximately 40,000 requiring hospitalizations, making burn injuries a persistent public health concern. Therefore, the rising incidence of chronic wounds and burn injuries is driving growth in the stratagraft market.
What are the major segments of the stratagraft market?
The stratagraft market covered in this report is segmented –
1) By Indication: Thermal Burns; Full-Thickness Burns
2) By Formulation: Allogeneic Cultured Keratinocytes; Dermal Fibroblasts
3) By End User: Hospitals; Specialized Wound Care Centers; Outpatient Care
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/stratagraft-global-market-report
Which companies dominate the stratagraft market?
Major companies operating in the stratagraft market are Mallinckrodt Pharmaceuticals plc
What major trends will shape the stratagraft market during the forecast period?
The key trend in the stratagraft market is focusing on developing innovative allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen to enhance wound healing capabilities and provide a viable alternative to autografts for treating severe burns and skin injuries. Allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen refer to a specialized biological construct used for skin regeneration and wound healing, particularly in treating severe burns and skin injuries. For instance, Mallinckrodt Pharmaceuticals, a US-based pharmaceutical company, announced the development of StrataGraft, a novel treatment for adults with deep partial-thickness thermal burns that contain intact dermal elements approved by the Food and Drug Administration, a US-based government agency. This product is composed of allogeneic cultured keratinocytes and dermal fibroblasts embedded in murine collagen, designed to promote healing and reduce the need for autografting, which is the traditional method of using a patient’s own skin for wound closure.
What are the key regional dynamics of the stratagraft market, and which region leads in market share?
North America was the largest region in the stratagraft market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the stratagraft market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The StrataGraft Market Report 2025 Offer?
The stratagraft market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
StrataGraft is a bioengineered, allogeneic skin substitute designed to treat deep partial-thickness burns and other complex skin defects. It is composed of both dermal and epidermal layers, made from human keratinocytes and dermal fibroblasts grown on a collagen scaffold.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20359
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
